GridAI Technologies Corp. Common Stock (GRDX)

About GRDX

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kin…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Website

www.grid-ai.com

Fundamentals

1-day range

$3.67$4.25

Market cap

$20.12M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-4.14

Dividend yield

—

Beta

—

Avg. volume

101.3K

GridAI Technologies Corp. Common Stock Competitors

Chosen by industry and closest market cap.

• GRDX

  GridAI Technologies Corp. Common Stock

  $4.05

  ▲ 1.00%
  Market cap $20.12MP/E —
  $1.65$6.93
• MRKR

  Marker Therapeutics Inc. Common Stock

  $1.37

  ▼ 7.12%
  Market cap $20.34MP/E —
  $0.8099$2.46
• PLRZ

  Polyrizon Ltd. Ordinary Shares

  $12.7

  ▼ 0.78%
  Market cap $19.82MP/E —
  $2.88$18.2
• SKYE

  Skye Bioscience Inc. Common Stock

  $1.81

  ▼ 7.18%
  Market cap $20.53MP/E —
  $1.84$39.92
• ALLR

  Allarity Therapeutics Inc. Common Stock

  $1.41

  ▲ 2.17%
  Market cap $19.64MP/E —
  $0.769$2.06
• DARE

  Dare Bioscience Inc. Common Stock

  $0.7437

  ▲ 0.64%
  Market cap $19.17MP/E —
  $0.72$3.78
• NEUP

  Neuphoria Therapeutics Inc. Common Stock

  $3.82

  ▲ 1.33%
  Market cap $21.24MP/E —
  $3.19$21.4

P/E shows — for peers not currently carrying a live signal of their own.

• Jason David Sawyer · June 30, 2026 · Grant

  250.0K
• Jason David Sawyer · March 31, 2026 · Grant

  250.0K

Institutional Ownership

March 31, 2026

Total shares held

332.2K

Total value held

$671.1K

Institutional holders

13